drugset / Trial / NCT04044534
Intranasal Insulin for Posttraumatic Stress Disorder
RandomizedCrossoverQuadruple-blindTreatment
Summary
To evaluate if intranasal insulin is effective in reducing PTSD symptoms.
Timeline
- Start
- 2024-10-31
- Primary completion
- 2026-05-28
- Completion
- 2026-05-28
Outcome
Missed primary endpoint
registry analysis (superiority test); Intranasal Insulin vs Placebo; p = 0.965; t-test, 2 sided NCT04044534 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | 40 iu | Intranasal |